InvestorsHub Logo
Followers 3
Posts 1277
Boards Moderated 1
Alias Born 04/02/2003

Re: None

Monday, 08/27/2007 1:32:55 PM

Monday, August 27, 2007 1:32:55 PM

Post# of 26


12:30PM Celsion announces Acceleration Plans for Its Breast Cancer Phase I Study (CLN) 5.71 +0.06 : Co announces that it has reached agreement with investigators at Duke University to supplement the Phase I dose escalation study for recurrent breast cancer at the chest wall, currently being performed under an investigator I.N.D at Duke University, through the filing of a Company I.N.D using the same clinical protocol. Celsion plans to add up to three additional sites in the study.